http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109912571-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2019-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109912571-B |
| titleOfInvention | Novel benzoquinoline substituted triazole compound with biological activity and synthesis method and application thereof |
| abstract | The invention discloses a novel benzoquinoline substituted triazole compound with bioactivity and a synthesis method and application thereof, belonging to the technical field of benzoquinoline and triazole derivatives with bioactivity. The technical scheme provided by the invention has the key points that: the novel benzoquinoline substituted triazole compound with biological activity has a structural formula as follows: the novel benzoquinoline substituted triazole compound with biological activity is used as an enzyme activity inhibitor of SHP1 target and an enzyme activity inhibitor of SHP1 target for preparing anticancer drugs. In view of the good activity of the benzoquinoline group and the triazole compound, the invention introduces the benzoquinoline group into triazole according to the active splicing principle to obtain the novel benzoquinoline substituted triazole compound with bioactivity, and has better application prospect in the field of preparation of anti-cancer drugs. |
| priorityDate | 2019-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.